This presentation will review the need for a precision medicine approach to opioid withdrawal and illustrate how variability in withdrawal symptom expression would inform novel treatment strategies. Differences in withdrawal presentation as a result of illicit fentanyl exposure will be reviewed and results from a randomized trial comparison of a new medication for withdrawal management will be presented